Powered by LiquidBiopsy, ClearID provides a minimally-invasive tool to monitor cancer patients, enabling more frequent testing and real-time molecular profiling of tumor DNA. Leveraging patented cell enrichment technology, the test analyzes patients' individual mutations to match them with targeted cancer therapies and clinical trials.
Kami ay gumagamit ng cookies para sa mga rekomendasyon ng content, pagsukat ng traffic, at mga personalized ads. Sa pag-gamit ng website na ito, ikaw ay pumapayag sa at .